DexCom Stock (NASDAQ: DXCM) stock price, news, charts, stock research, profile.
Open | $136.070 |
Close | $133.860 |
Volume / Avg. | 3.222M / 3.055M |
Day Range | 132.875 - 136.640 |
52 Wk Range | 74.750 - 142.000 |
Market Cap | $51.466B |
P/E Ratio | 105.015 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 48 |
Short Interest | 4.28% |
Days to Cover | 6.06 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of DexCom (NASDAQ: DXCM) through any online brokerage.
Other companies in DexCom’s space includes: Steris (NYSE:STE), Masimo (NASDAQ:MASI), Koninklijke Philips (NYSE:PHG), Smith & Nephew (NYSE:SNN) and Abbott Laboratories (NYSE:ABT).
The latest price target for DexCom (NASDAQ: DXCM) was reported by UBS on Wednesday, April 10, 2024. The analyst firm set a price target for 163.00 expecting DXCM to rise to within 12 months (a possible 22.10% upside). 29 analyst firms have reported ratings in the last year.
The stock price for DexCom (NASDAQ: DXCM) is $133.5001 last updated April 17, 2024 at 6:34 PM EDT.
There are no upcoming dividends for DexCom.
DexCom’s Q1 earnings are confirmed for Thursday, April 25, 2024.
There is no upcoming split for DexCom.
DexCom is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.